Search Results - "HASSOUN, HANI"

High Incidence of Thromboembolic Events in Patients Treated With Cisplatin-Based Chemotherapy: A Large Retrospective Analysis by MOORE, Russell A, ADEL, Nelly, RIEDEL, Elyn, BHUTANI, Manisha, FELDMAN, Darren R, ELISE TABBARA, Nour, SOFF, Gerald, PARAMESWARAN, Rekha, HASSOUN, Hani

“…This study was designed to determine the incidence of venous and arterial thromboembolic events (TEEs) in patients treated with cisplatin-based chemotherapy…”
Get full text

Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma by McCarthy, Philip L, Owzar, Kouros, Hofmeister, Craig C, Hurd, David D, Hassoun, Hani, Richardson, Paul G, Giralt, Sergio, Stadtmauer, Edward A, Weisdorf, Daniel J, Vij, Ravi, Moreb, Jan S, Callander, Natalie Scott, Van Besien, Koen, Gentile, Teresa, Isola, Luis, Maziarz, Richard T, Gabriel, Don A, Bashey, Asad, Landau, Heather, Martin, Thomas, Qazilbash, Muzaffar H, Levitan, Denise, McClune, Brian, Schlossman, Robert, Hars, Vera, Postiglione, John, Jiang, Chen, Bennett, Elizabeth, Barry, Susan, Bressler, Linda, Kelly, Michael, Seiler, Michele, Rosenbaum, Cara, Hari, Parameswaran, Pasquini, Marcelo C, Horowitz, Mary M, Shea, Thomas C, Devine, Steven M, Anderson, Kenneth C, Linker, Charles

“…In patients who had undergone stem-cell transplantation, lenalidomide maintenance therapy improved progression-free and overall survival, though at the expense…”
Get full text

Accelerated single cell seeding in relapsed multiple myeloma by Landau, Heather J., Yellapantula, Venkata, Diamond, Benjamin T., Rustad, Even H., Maclachlan, Kylee H., Gundem, Gunes, Medina-Martinez, Juan, Ossa, Juan Arango, Levine, Max F., Zhou, Yangyu, Kappagantula, Rajya, Baez, Priscilla, Attiyeh, Marc, Makohon-Moore, Alvin, Zhang, Lance, Boyle, Eileen M., Ashby, Cody, Blaney, Patrick, Patel, Minal, Zhang, Yanming, Dogan, Ahmet, Chung, David J., Giralt, Sergio, Lahoud, Oscar B., Peled, Jonathan U., Scordo, Michael, Shah, Gunjan, Hassoun, Hani, Korde, Neha S., Lesokhin, Alexander M., Lu, Sydney, Mailankody, Sham, Shah, Urvi, Smith, Eric, Hultcrantz, Malin L., Ulaner, Gary A., van Rhee, Frits, Morgan, Gareth J., Landgren, Ola, Papaemmanuil, Elli, Iacobuzio-Donahue, Christine, Maura, Francesco

“…Multiple myeloma (MM) progression is characterized by the seeding of cancer cells in different anatomic sites. To characterize this evolutionary process, we…”
Get full text

Phase I Trial of Bevacizumab Plus Escalated Doses of Sunitinib in Patients With Metastatic Renal Cell Carcinoma by FELDMAN, Darren R, BAUM, Michael S, MOTZER, Robert J, GINSBERG, Michelle S, HASSOUN, Hani, FLOMBAUM, Carlos D, VELASCO, Susanne, FISCHER, Patricia, RONNEN, Ellen, ISHILL, Nicole, PATIL, Sujata

“…Both bevacizumab and sunitinib target the vascular endothelial growth factor pathway and demonstrate activity against advanced renal cell carcinoma (RCC). In…”
Get full text

Evaluating serum free light chain ratio as a biomarker in multiple myeloma by Akhlaghi, Theresia, Maclachlan, Kylee, Korde, Neha, Mailankody, Sham, Lesokhin, Alexander, Hassoun, Hani, Lu, Sydney X, Patel, Dhwani, Shah, Urvi, Tan, Carlyn, Derkach, Andriy, Lahoud, Oscar, Landau, Heather J, Shah, Gunjan L, Scordo, Michael, Chung, David J, Giralt, Sergio A, Usmani, Saad Z, Landgren, Ola, Hultcrantz, Malin

“…Not available.Not available…”
Get full text

Single-Agent Bortezomib in Previously Untreated Multiple Myeloma: Efficacy, Characterization of Peripheral Neuropathy, and Molecular Correlations With Response and Neuropathy by RICHARDSON, Paul G, WANLING XIE, KESARI, Santosh, BRIEMBERG, Hannah R, SCHLOSSMAN, Robert L, MUNSHI, Nikhil C, THOMPSON HEFFNER, L, DOSS, Deborah, ESSELTINE, Dixie-Lee, WELLER, Edie, ANDERSON, Kenneth C, AMATO, Anthony A, MITSIADES, Constantine, CHANAN-KHAN, AsherA, LONIAL, Sagar, HASSOUN, Hani, AVIGAN, David E, OAKLANDER, Anne Louise, KUTER, David J, WEN, Patrick Y

“…PURPOSE To assess efficacy and safety of single-agent bortezomib in previously untreated patients with multiple myeloma, investigate prevalence of baseline and…”
Get full text

Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls by Shah, Urvi A, Rögnvaldsson, Sæmundur, Derkach, Andriy, Björkholm, Magnus, Turesson, Ingemar, David, Yael, Hultcrantz, Malin, Tan, Carlyn, Hassoun, Hani, Korde, Neha, Lesokhin, Alexander, Mailankody, Sham, Kristinsson, Sigurður Yngvi, Landgren, C Ola

Get full text

Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through The International Kidney and Monoclonal Gammopathy Research Group by Havasi, Andrea, Heybeli, Cihan, Leung, Nelson, Angel-Korman, Avital, Sanchorawala, Vaishali, Cohen, Oliver, Wechalekar, Ashutosh, Bridoux, Frank, Jaffer, Insara, Gutgarts, Victoria, Hassoun, Hani, Levinson, Maya, Rosenbaum, Cara, Milani, Paolo, Palladini, Giovanni, Merlini, Giampaolo, Hegenbart, Ute, Schönland, Stefan, Veelken, Kaya, Pogrebinsky, Alexander, Doros, Gheorghe, Landau, Heather

“…Effective systemic therapies suppress toxic light chain production leading to an increased proportion of patients with light chain (AL) amyloidosis who survive…”
Get full text

Nutrition perceptions, needs and practices among patients with plasma cell disorders by Malik, Maria A., Sweeney, Nathan W., Jafri, Mohammad, Derkach, Andriy, Chmielewski, Cynthia, Adintori, Peter A., Mailankody, Sham, Korde, Neha, Tan, Carlyn R., Hassoun, Hani, Hultcrantz, Malin, Hillengass, Jens, McCann, Susan E., Iyengar, Neil, Usmani, Saad, Giralt, Sergio A., Landgren, Ola, van den Brink, Marcel R. M., Ahlstrom, Jennifer M., Lesokhin, Alexander M., D’Souza, Anita, Chimonas, Susan, Shah, Urvi A.

Get full text

Cardiac ALL: Most Unusual Occurrence of Lenalidomide-associated Acute Lymphoblastic Leukemia with Subsequent Cardiac Involvement by Sharma, Naman, Hassoun, Hani, Hatem, Joseph, Kouides, Peter

“…Leukemic infiltration of the myocardium is an extremely rare complication and requires high clinical suspicion, as <5% pf patients are symptomatic. Commonly…”
Get full text

Author Correction: Accelerated single cell seeding in relapsed multiple myeloma by Landau, Heather J., Yellapantula, Venkata, Diamond, Benjamin T., Rustad, Even H., Maclachlan, Kylee H., Gundem, Gunes, Medina-Martinez, Juan, Ossa, Juan Arango, Levine, Max F., Zhou, Yangyu, Kappagantula, Rajya, Baez, Priscilla, Attiyeh, Marc, Makohon-Moore, Alvin, Zhang, Lance, Boyle, Eileen M., Ashby, Cody, Blaney, Patrick, Patel, Minal, Zhang, Yanming, Dogan, Ahmet, Chung, David J., Giralt, Sergio, Lahoud, Oscar B., Peled, Jonathan U., Scordo, Michael, Shah, Gunjan, Hassoun, Hani, Korde, Neha S., Lesokhin, Alexander M., Lu, Sydney, Mailankody, Sham, Shah, Urvi, Smith, Eric, Hultcrantz, Malin L., Ulaner, Gary A., van Rhee, Frits, Morgan, Gareth J., Landgren, Ola, Papaemmanuil, Elli, Iacobuzio-Donahue, Christine, Maura, Francesco

“…A Correction to this paper has been published: https://doi.org/10.1038/s41467-021-20978-y…”
Get full text

Comparison of infectious complications with BCMA-directed therapies in multiple myeloma by Nath, Karthik, Shekarkhand, Tala, Nemirovsky, David, Derkach, Andriy, Costa, Bruno Almeida, Nishimura, Noriko, Farzana, Tasmin, Rueda, Colin, Chung, David J., Landau, Heather J., Lahoud, Oscar B., Scordo, Michael, Shah, Gunjan L., Hassoun, Hani, Maclachlan, Kylee, Korde, Neha, Shah, Urvi A., Tan, Carlyn Rose, Hultcrantz, Malin, Giralt, Sergio A., Usmani, Saad Z., Shahid, Zainab, Mailankody, Sham, Lesokhin, Alexander M.

“…B-cell-maturation-antigen (BCMA)-directed therapies are highly active for multiple myeloma, but infections are emerging as a major challenge. In this…”
Get full text

Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma by Costa, Bruno Almeida, Flynn, Jessica, Nishimura, Noriko, Devlin, Sean M., Farzana, Tasmin, Rajeeve, Sridevi, Chung, David J., Landau, Heather J., Lahoud, Oscar B., Scordo, Michael, Shah, Gunjan L., Hassoun, Hani, Maclachlan, Kylee, Hultcrantz, Malin, Korde, Neha, Lesokhin, Alexander M., Shah, Urvi A., Tan, Carlyn R., Giralt, Sergio A., Usmani, Saad Z., Nath, Karthik, Mailankody, Sham

“…Despite being the mainstay of management for cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS), there is…”
Get full text

Incremental Value of Global Longitudinal Strain for Predicting Survival in Patients With Advanced AL Amyloidosis by Lee Chuy, Katherine, Drill, Esther, Yang, Ji Can, Landau, Heather, Hassoun, Hani, Nahhas, Omar, Chen, Carol L., Yu, Anthony F., Steingart, Richard M., Liu, Jennifer E.

“…Advanced light-chain (AL) amyloidosis is associated with poor prognosis, with a 5-year survival rate of <25%. Prognostication is based on the revised Mayo…”
Get full text

Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity by Lendvai, Nikoletta, Tsakos, Ioanna, Devlin, Sean M., Schaffer, Wendy L., Hassoun, Hani, Lesokhin, Alexander M., Landau, Heather, Korde, Neha, Mailankody, Sham, Smith, Eric, Chung, David J., Koehne, Guenther, Shah, Gunjan L., Alexander, Aeri, Patel, Minal, Ballagi, Andrea, Grundberg, Ida, Giralt, Sergio A., Landgren, Ola

Get full text

Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma by Tan, Carlyn Rose, Derkach, Andriy, Nemirovsky, David, Ciardiello, Amanda, Diamond, Benjamin, Hultcrantz, Malin, Hassoun, Hani, Mailankody, Sham, Shah, Urvi, Maclachlan, Kylee, Patel, Dhwani, Lahoud, Oscar B., Landau, Heather J., Chung, David J., Shah, Gunjan L., Scordo, Michael, Giralt, Sergio A., Lesokhin, Alexander, Usmani, Saad Z., Landgren, Ola, Korde, Neha

“…Lenalidomide and dexamethasone with bortezomib (VRd) or carfilzomib (KRd) are commonly used induction regimens in the U.S. This single-center, retrospective…”
Get full text

Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma by Hultcrantz, Malin, Hassoun, Hani, Korde, Neha, MacLachlan, Kylee, Mailankody, Sham, Patel, Dhwani, Shah, Urvi A., Tan, Carlyn Rose, Chung, David J., Lahoud, Oscar B., Landau, Heather J., Scordo, Michael, Shah, Gunjan L., Giralt, Sergio A., Pianko, Matthew J., Burge, Miranda, Barnett, Kelly, Salcedo, Meghan, Caple, Julia, Tran, Linh, Blaslov, Jenna, Shekarkhand, Tala, Hamid, Selena, Nemirovsky, David, Derkach, Andriy, Arisa, Oluwatobi, Peer, Cody J., Figg, William D., Usmani, Saad Z., Landgren, Ola, Lesokhin, Alexander M.

Get full text

P962: COMMERCIAL TECLISTAMAB IN ANTI‐BCMA THERAPY EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS: THE MSKCC EXPERIENCE by Firestone, Ross, Shekarkhand, Tala, Patel, Dhwani, Hultcrantz, Malin, Lesokhin, Alexander, Mailankody, Sham, Hassoun, Hani, Tan, Carlyn, Shah, Urvi, Korde, Neha, Maclachlan, Kylee, Landau, Heather, Chung, David, Shah, Gunjan, Giralt, Sergio, Lahoud, Oscar, Usmani, Saad

Get full text

Vertebral Uptake of Tc-99m Macroaggregated Albumin (MAA) with SPECT/CT Occurring in Superior Vena Cava Obstruction by Karls, Shawn, Hassoun, Hani, Derbekyan, Vilma

“…A 67-year-old male presented with dyspnea for which lung scintigraphy was ordered to rule out pulmonary embolus. Planar images demonstrated abnormal midline…”
Get full text

Vertebral Uptake of Tc-99m Macroaggregated Albumin (MAA) with SPECT/CT Occurring in Superior Vena Cava Obstruction by Karls, Shawn, Hassoun, Hani, Derbekyan, Vilma

“…A 67-year-old male presented with dyspnea for which lung scintigraphy was ordered to rule out pulmonary embolus. Planar images demonstrated abnormal midline…”
Get full text